370 / 1631
Conclusion – PET Adapted RT Use in Advanced
Stage HL
• GHSG does not provide any direct evidence that RT
can be omitted in PET negative cases after ABVD.
• Prior evidence illustrates that it is a mistake to extrapolate RT
effect after BEACOPP to AVBD-treated patients.
• Trials in early unfavourable HL suggest that omitting
RT based on PET will increase relapse rate.
• The significance of the effect is debatable
.
• The GITIL/FIL HD0607 results will shed light on the
question.